| Literature DB >> 30648471 |
Claire Crowley1, Colin R Butler1,2, Carlotta Camilli1, Robert E Hynds2, Krishna K Kolluri2, Sam M Janes2, Paolo De Coppi1, Luca Urbani1,3.
Abstract
IMPACT STATEMENT: Methodologies for incorporation of cells into tissue-engineered grafts, particularly at the later preclinical stages, are suboptimal and non-validated, and monitoring cell fate within scaffolds cultured in bioreactors and in vivo is challenging. In this study, we demonstrate how bioluminescence imaging (BLI) can overcome these difficulties and allow quantitative cell tracking at multiple stages of the bioengineering preclinical pipeline. Our robust bioluminescence-based approach allowed reproducible longitudinal monitoring of mesoangioblast localization and survival in 2D/3D tissue culture, in organ-scale bioreactors, and in vivo. Our findings will encourage the use of BLI in tissue engineering studies, improving the overall quality of cell-scaffold interaction research.Entities:
Keywords: bioluminescence; tissue engineering; tissue scaffolds; transplantation
Mesh:
Year: 2019 PMID: 30648471 PMCID: PMC6389770 DOI: 10.1089/ten.TEC.2018.0351
Source DB: PubMed Journal: Tissue Eng Part C Methods ISSN: 1937-3384 Impact factor: 3.056